Biogen Inc.

Healthcare · Drug Manufacturers - General

227.50$ +1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Biogen Inc. (BIIB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 29,440 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIIB
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	635	814	925	1,278	1,432	1,721	2,007	9,504	9,166	8,367	8,553	8,629	8,479	8,552	8,092	9,050	10,130	11,863	14,317	19,505	22,877	23,653	25,289	27,234	24,619	23,877	24,554	26,845	28,049	29,440
Current Assets	436	596	694	910	928	1,098	1,216	1,839	1,931	1,618	1,713	2,368	2,458	2,481	2,540	2,975	3,244	3,185	4,673	6,700	8,732	7,873	7,641	8,382	6,887	7,857	9,791	6,859	7,457	8,974
Cash	62	70	25	57	49	54	45	315	209	568	661	660	622	582	760	515	571	603	1,205	1,308	2,327	1,574	1,225	2,914	1,331	2,261	3,419	1,050	2,375	3,009
Cash & Short-Term Investments	321	440	517	655	682	798	867	836	1,058	851	903	1,184	1,371	1,264	1,208	1,691	1,706	1,223	1,845	3,429	4,895	3,689	3,538	4,476	2,610	3,803	4,893	1,050	2,375	3,816
Receivables	43	87	101	137	143	178	105	199	450	468	539	596	667	761	840	831	955	1,077	1,576	1,227	1,442	1,787	2,485	2,471	2,327	1,962	2,136	2,100	1,869	1,867
Inventory	48	37	27	51	40	44	34	496	251	183	169	234	264	294	289	327	447	659	804	893	1,002	903	930	804	1,069	1,352	1,344	2,527	2,461	2,168
Property, Plant & Equipment	–	–	–	–	48	109	265	1,253	1,525	1,174	1,280	1,497	1,595	1,637	1,642	1,571	1,742	1,751	1,766	2,188	2,502	3,182	3,601	3,247	3,412	3,416	3,299	–	–	–
Goodwill	–	–	–	–	–	–	–	1,151	1,151	1,130	1,155	1,137	1,139	1,139	1,146	1,146	1,201	1,233	1,760	2,664	3,669	4,633	5,706	5,758	5,762	5,761	5,749	6,219	6,479	6,491
Intangible Assets	10	15	16	14	14	17	16	3,639	3,293	2,976	2,747	2,492	2,161	1,871	1,773	1,608	1,632	4,475	4,029	4,085	3,808	3,880	3,120	3,527	3,084	2,221	1,850	8,363	9,691	9,179
Total Liabilities	150	278	206	298	325	372	412	2,451	2,339	1,461	1,403	3,095	2,673	2,290	2,643	2,623	3,166	3,242	3,503	10,130	10,748	11,055	12,257	13,895	13,933	12,918	11,166	12,045	11,333	11,183
Current Liabilities	88	124	131	190	221	295	56	405	1,261	583	583	2,189	923	715	1,050	913	1,657	1,758	2,220	2,578	3,337	3,368	3,295	4,864	3,742	4,298	3,273	3,434	5,529	3,349
Short-Term Debt	4.0	30	4.9	4.9	4.9	4.9	4.9	94	748	337	–	1,511	28	20	137	3.3	453	3.5	3.1	4.8	4.7	3.2	–	1,496	166	999	194	150	1,749	80
Accounts Payable	16	16	25	30	38	51	3.9	63	121	100	100	91	107	119	163	186	204	220	229	267	280	396	371	531	455	589	492	403	424	432
Long-Term Debt	–	–	–	–	129	136	866	887	102	43	97	52	1,085	1,080	1,066	1,061	687	592	582	6,522	6,513	5,935	5,937	4,459	7,426	6,274	6,281	6,788	4,547	6,287
Shareholders' Equity	484	536	719	980	1,106	1,349	1,595	7,053	6,826	6,906	7,150	5,534	5,806	6,222	5,397	6,427	6,962	8,620	10,814	9,375	12,129	12,598	13,040	13,343	10,700	10,896	13,398	14,799	16,716	18,257
Retained Earnings	13	25	214	352	544	706	263	-612	-801	-1,022	-861	-352	270	1,069	1,872	3,107	4,487	6,349	9,284	12,208	15,072	15,810	16,257	16,455	13,976	13,912	16,467	17,628	19,260	20,553
Shares Outstanding	923	927	946	473	464	399	399	334	343	346	345	320	295	289	255	245	240	238	237	231	219	213	205	187	161	150	146	146	146	147

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings